EFTR
Closed
Effector Therapeutics Inc
0.0003
0.0000 (0.00%)
Last Update: 01 Jul 2025 18:56:00
Yesterday: 0.0003
Day's Range: 0.0002 - 0.0003
Send
sign up or login to leave a comment!
When Written:
0.3527
Effector Therapeutics Inc is a biopharmaceutical company that focuses on developing novel small molecule drugs for the treatment of cancer. The company's proprietary technology platform, called eFFECTOR, targets specific cellular pathways that are critical for cancer cell survival and proliferation. Effector's lead drug candidate, eFT508, is a potent inhibitor of multiple cancer-causing pathways, including the MAPK and PI3K/AKT/mTOR pathways. The company is also developing other drugs that target specific cancer types and mutations, including KRAS-mutant cancers. Effector Therapeutics was founded in 2012 and is headquartered in San Diego, California.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








